Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
21-Nov-09 Standard & Poor's Quantitative Report N/A ARYx Therapeutics 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ARYX THERAPEUTIC -- ARYX 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS 3 $4 View Abstract
13-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ARYX THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
12-Nov-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
6-Nov-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
6-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Aryx Therapeutics, Incorporation 40 $65 View Abstract
31-Oct-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
27-Oct-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
26-Oct-09 PriceTarget Research, Inc. N/A ARYx Therapeutics has a current Overall Rating of D (Negative). 7 $25 View Abstract
Next 9

Independent Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price More Info
21-Nov-09 Standard & Poor's Quantitative Report N/A ARYx Therapeutics 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ARYX THERAPEUTIC -- ARYX 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS 3 $4 View Abstract
13-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ARYX THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
12-Nov-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
6-Nov-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
6-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Aryx Therapeutics, Incorporation 40 $65 View Abstract
31-Oct-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
27-Oct-09 Zacks Investment Research Inc. N/A ARYX THERAPEUT (ARYX) Zacks Company Snapshot 1 $10 View Abstract
26-Oct-09 PriceTarget Research, Inc. N/A ARYx Therapeutics has a current Overall Rating of D (Negative). 7 $25 View Abstract
Next 9

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.